GSK holds scientific symposium for Bonviva

Published: 2006-12-07 06:57:00

Updated: 2006-12-07 06:57:00

GSK said on December 3 that it sponsored its scientific symposium for Bonviva (ibandronate), the first and only once-monthly tablet for the effective treatment of postmenopausal osteoporosis prior to its launching in the first half of next year.

Professor Phillip Shambrook at Sydney University gave his lecture on clinical benefits of Bonviva in that symposium where 250 Korean endocrine speci...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.